FDA chief has no ‘plans’ for abortion pill policy changes but continues safety review
Food and Drug Administration Commissioner Marty Makary said in a recent interview he has “no preconceived plans” to modify policies surrounding abortion pill mifepristone, which is designed to end a pregnancy in the first 10 weeks. “We have an ongoing review of safety data on mifepristone, which is a requirement from the prior administrations,” Makary…

